The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Distinct outcomes in Hispanic/Latinx and non-Hispanic/Latinx patients with metastatic renal cell carcinoma (mRCC) treated with first-line ipilimumab plus nivolumab (ipi/nivo).
 
Sana Ali
No Relationships to Disclose
 
Sally Leong
No Relationships to Disclose
 
Luis A Meza
No Relationships to Disclose
 
Nazli Dizman
Consulting or Advisory Role - Vivreon Biosciences
 
Zeynep Busra Zengin
No Relationships to Disclose
 
Tane Kim
No Relationships to Disclose
 
Youngju Pak
No Relationships to Disclose
 
Mykola Onyshchenko
Consulting or Advisory Role - Bayer; Blueprint Medicines; Sanofi/Regeneron
Speakers' Bureau - Natera
 
Sumanta K. Pal
Consulting or Advisory Role - F. Hoffmann LaRoche; F. Hoffmann LaRoche; Roche
Research Funding - Eisai (Inst); Exelixis (Inst); Genentech (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Genentech; Seagen
 
Alex Chehrazi-Raffle
No Relationships to Disclose